Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Will Thermo Fisher’s (TMO) CFO Transition Reshape Its Succession Strategy and Management Outlook?

2025-09-13
Thermo Fisher Scientific recently presented at the Morgan Stanley Global Healthcare Conference and announced that CFO Stephen Williamson will retire in March 2026, with James R. Meyer named as his successor, while the CEO sold US$200,000 in shares under a pre-arranged plan. These leadership changes and executive share sales come amid shifting analyst sentiment and highlight the importance of management continuity during a period of industry transformation and investor attention to succession...

Why Thermo Fisher (TMO) Stock Is Trading Up Today

2025-09-11
Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 2.7% in the afternoon session after Barclays upgraded the stock to Overweight from Equalweight and boosted its price target, citing a more attractive valuation and clearer growth outlook.

Micron, FedEx, Thermo Fisher Scientific: Analyst moves

2025-09-11
Some of the stories Wall Street is watching on Thursday, Sept, 11 include Citi raising its price target on shares of Micron Technology (MU), Bank of America downgrading FedEx (FDX), and Barclays upgrading shares of Thermo Fisher Scientific (TMO). Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market

2025-09-11
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market

Apple downgraded, Nvidia upgraded: Wall Street's top analyst calls

2025-09-11
Apple downgraded, Nvidia upgraded: Wall Street's top analyst calls

1 Healthcare Stock for Long-Term Investors and 2 We Brush Off

2025-09-11
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped the upside for healthcare stocks lately as the industry’s flat return over the past six months has trailed the S&P 500’s 17.4% gain.

Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market

2025-09-10
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market

Here’s What Dragged Thermo Fisher Scientific (TMO) in Q2

2025-09-10
Renaissance Investment Management, an investment management company, released its Q2 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market experienced significant volatility in the second quarter, and yet, the S&P 500 posted an all-time high by the end of June. The liberation day tariff announcement […]

Thermo Fisher Expands Reach with Solventum Buy

2025-09-10
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the undervalued wide moat stocks to buy now. On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the completion of its acquisition of Solventum Corporation’s purification and filtration business. This $4.0 billion transaction is aimed at expanding the company’s bioprocessing and adjacent market offerings. While providing growth and synergy […]

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market

2025-09-09
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market